Global Oral Cancer Treatment Market Growth (Status and Outlook) 2023-2029

Global Oral Cancer Treatment Market Growth (Status and Outlook) 2023-2029

Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa.

LPI (LP Information)' newest research report, the “Oral Cancer Treatment Industry Forecast” looks at past sales and reviews total world Oral Cancer Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Cancer Treatment sales for 2023 through 2029. With Oral Cancer Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Cancer Treatment industry.

This Insight Report provides a comprehensive analysis of the global Oral Cancer Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Cancer Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Cancer Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Cancer Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Cancer Treatment.

The global Oral Cancer Treatment market size is projected to grow from US$ 2320.4 million in 2022 to US$ 3084.4 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.

There are several types of oral cancers, but around 90% are squamous cell carcinomas, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), lips, or palate (roof of the mouth). In 2013 oral cancer resulted in 135,000 deaths up from 84,000 deaths in 1990. Five-year survival rates in the United States are 63%.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Cancer Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Squamous Cell Carcinoma
Verrucous Carcinoma
Minor Salivary Gland Carcinomas
Lymphomas

Segmentation by application
Hospitals & Clinics
Research Organization
Academic Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Qilu Pharmaceutical
Teva Pharmaceutical Industries
Eli Lilly And Company
Roche
Merck
Novartis
Pfizer

Please note: The report will take approximately 2 business days to prepare and deliver.